McMaster University

McMaster University

Ranjan Sur

[BACK]
Photo Biography, contacts and additional information
Photo of Ranjan Sur

MBBS (Osmania University). MD. (Chandigarh). PhD (Witwatersrand). DNB (Radiation Oncology)., F.C.Rad (Onc)., FRCPC

Professor, McMaster University 
Department of Oncology- Division of Radiation Oncology
Associate Member - Department of Medicine

Contacts

P: 905-387-9711 ext. 63123
F: 905-575-6326
E: sur@hhsc.ca

Juravinski Cancer Centre
3rd Floor 
699 Concession Street 
Hamilton Ontario, L8V 5C2

 

Enter email below for mentorship availability checker, or leave empty to disable:

Academic Interests

Dr. Sur's research interests include; high dose brachytherapy in esophageal, lung and cervical cancers and radiation oncology research in esophageal cancer, lung cancer, GIT malignancies, gynecological malignancies, head and neck cancer radiotherapy fractionation, chemo sensitization and chemical modifiers. Dr.Sur leads the brachytherapy program at the Juravinski Cancer Centre.

Selected Publications

  • Sur R.K., Levin C.V., Donde B., Sharma V., Miszczyk L., Nag S. Prospective randomized trail of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma- An International Atomic Energy Agency Study. International Journal of Radiation Oncology Biology Physics 2002; 53: 127- 33
  • Sur R.K., Donde B., Falkson C., Ahmed S.N., Levin V., Nag S., Wong R., Jones G. Randomized prospective study comparing high-dose-rate intraluminal brachytherapy (HDRILBT) alone with HDRILBT and external beam radiotherapy in the palliation of advanced esophageal Cancer. Brachytherapy 2004; 3(4): 191-5.
  • Bonner J.A., Harari P.M., Giralt J., Azarnia N., Shin D.M., Cohen R.B., Jones C.U., Sur R., Raben D., Jassem J., Ove R., Kies M.S., Baselga J., Youssoufian H, Amellal N., Rowinsky E.K., Ang K.K. Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck. New England Journal of Medicine 2006; 354(6):567-78.

Search for publications for Dr. Sur on PubMed

Valid XHTML 1.0 Transitional Level Double-A conformance, W3C WAI Web Content Accessibility Guidelines 2.0